These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
166 related articles for article (PubMed ID: 15080176)
1. Despite the data, HIV harm reduction programs remain a hard sell in many countries. Hoover J AIDS; 2003; 17 Suppl 4():S22-4. PubMed ID: 15080176 [No Abstract] [Full Text] [Related]
3. Guidelines for better harm reduction: evaluating implementation of best practice recommendations for needle and syringe programs (NSPs). Strike C; Watson TM; Lavigne P; Hopkins S; Shore R; Young D; Leonard L; Millson P Int J Drug Policy; 2011 Jan; 22(1):34-40. PubMed ID: 20413288 [TBL] [Abstract][Full Text] [Related]
4. Impact of a harm-reduction programme on soft tissue infections among injecting drug users of Kolkata, India. Bhattacharya MK; Naik TN; Palit A; Bhattacharya SK J Health Popul Nutr; 2006 Mar; 24(1):121-2. PubMed ID: 16796159 [No Abstract] [Full Text] [Related]
5. Learning from HIV epidemics among injecting drug users. Jarlais DC Int J Drug Policy; 2010 Mar; 21(2):97-9. PubMed ID: 20018500 [TBL] [Abstract][Full Text] [Related]
6. Islam and harm reduction. Kamarulzaman A; Saifuddeen SM Int J Drug Policy; 2010 Mar; 21(2):115-8. PubMed ID: 20006483 [TBL] [Abstract][Full Text] [Related]
7. Late for the epidemic: HIV/AIDS in Eastern Europe. Cohen J Science; 2010 Jul; 329(5988):160, 162-4. PubMed ID: 20616262 [No Abstract] [Full Text] [Related]
8. Injection drug use and HIV transmission in Russia. Luo RF; Cofrancesco J AIDS; 2006 Apr; 20(6):935-6. PubMed ID: 16549981 [No Abstract] [Full Text] [Related]
9. Lower injection-related HIV-1 risk associated with participation in a harm reduction program in Kazan, Russia. Badrieva L; Karchevsky E; Irwin KS; Heimer R AIDS Educ Prev; 2007 Feb; 19(1):13-23. PubMed ID: 17411386 [TBL] [Abstract][Full Text] [Related]
10. Social representations of HIV/AIDS in five Central European and Eastern European countries: a multidimensional analysis. Goodwin R; Kwiatkowska A; Realo A; Kozlova A; Nguyen Luu LA; Nizharadze G AIDS Care; 2004 Aug; 16(6):669-80. PubMed ID: 15370056 [TBL] [Abstract][Full Text] [Related]
11. No opiate substitutes for the masses of IDUs. Cohen J Science; 2010 Jul; 329(5988):165-7. PubMed ID: 20616264 [No Abstract] [Full Text] [Related]
12. The Thai HIV/AIDS epidemic at 15 years: sustained needle sharing among southern Thai drug injectors. Perngmark P; Vanichseni S; Celentano DD Drug Alcohol Depend; 2008 Jan; 92(1-3):183-90. PubMed ID: 17870252 [TBL] [Abstract][Full Text] [Related]
13. The Global Fund's leadership on harm reduction: 2002-2009. Atun R; Kazatchkine M Int J Drug Policy; 2010 Mar; 21(2):103-6. PubMed ID: 20171865 [TBL] [Abstract][Full Text] [Related]
14. Making the case for harm reduction programs for injection drug users. Kulikowski J; Linder E Nursing; 2018 Jun; 48(6):46-51. PubMed ID: 29794629 [No Abstract] [Full Text] [Related]
15. 'Social evils' and harm reduction: the evolving policy environment for human immunodeficiency virus prevention among injection drug users in China and Vietnam. Hammett TM; Wu Z; Duc TT; Stephens D; Sullivan S; Liu W; Chen Y; Ngu D; Des Jarlais DC Addiction; 2008 Jan; 103(1):137-45. PubMed ID: 18028519 [TBL] [Abstract][Full Text] [Related]
16. Coexisting or conjoined: the growth of the international drug users' movement through participation with International Harm Reduction Association Conferences. Byrne J; Albert ER Int J Drug Policy; 2010 Mar; 21(2):110-1. PubMed ID: 19942422 [No Abstract] [Full Text] [Related]
17. Interpreting the relation between injection drug use and harm: a cautionary note. Anderson JF CMAJ; 2000 Jun; 162(12):1695-6. PubMed ID: 10870501 [No Abstract] [Full Text] [Related]
18. Implementing harm reduction for heroin users in Afghanistan, the worldwide opium supplier. Maguet O; Majeed M Int J Drug Policy; 2010 Mar; 21(2):119-21. PubMed ID: 20171864 [TBL] [Abstract][Full Text] [Related]
19. How much will it cost? Estimation of resource needs and availability for HIV prevention, treatment and care for people who inject drugs in Asia. Bergenstrom A; McLeod R; Sharma M; Mesquita F; Dorabjee J; Atun R; Lewis G; Rao JV Int J Drug Policy; 2010 Mar; 21(2):107-9. PubMed ID: 20144859 [TBL] [Abstract][Full Text] [Related]
20. [The characteristics of the epidemic process of HIV infection in the Armed Forces]. Zmushko EI; Bolekhan VN; Borzykh VA Voen Med Zh; 1998 Aug; 319(8):44-7. PubMed ID: 9793449 [No Abstract] [Full Text] [Related] [Next] [New Search]